Literature DB >> 7718622

Expression of fructosyllysine receptors on human monocytes and monocyte-like cell lines.

R Salazar1, R Brandt, S Krantz.   

Abstract

Short-term exposure of human serum albumin to glucose in vitro results in the formation of fructosyllysine residues. Using short-term glucose-modified albumin the interactions with human monocytes and with the human monocyte-like cells U937, MonoMac 6, HL60, and THP1 were studied. Short-term glycated albumin was specifically bound by monocytes, U937 and MonoMac 6 cells, but not by HL60 and THP1 cells. This specific binding of short-term glycated albumin was inhibited by fructosyllysine, but not by hexitollysine. Short-term glycated albumin did not compete for binding of albumin, modified by advanced glycation end products. Scatchard analysis of the binding data indicated that there are 10,000 binding sites per cell in monocytes or U937 cells and 2000 sites per cell on MonoMac 6 cells with affinity constants of 9 x 10(6) M-1. Specific binding of short-term glycated albumin to human monocytes was observed in 29% of the 101 human subjects investigated. Ligand-receptor cross-linking and ligand blotting experiments revealed two binding proteins of 100 to 110 and 190 kDa in SDS-PAGE after membrane protein solubilization of U937 and MonoMac 6 cells. The binding of short-term glycated albumin to MonoMac 6 cells induced the production of the cytokines IL-1 and TNF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718622     DOI: 10.1016/0167-4889(94)00221-y

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells.

Authors:  R Salazar; R Brandt; J Kellermann; S Krantz
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

2.  Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance.

Authors:  R Brandt; C Landmesser; L Vogt; B Hehmke; R Hanschke; J Kasbohm; K Hartmann; B Jäger; S Krantz; D Michaelis
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

3.  Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes.

Authors:  Krishna Adeshara; Rashmi Tupe
Journal:  Mol Biol Rep       Date:  2016-02-13       Impact factor: 2.316

4.  Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis.

Authors:  J J Li; D Dickson; P R Hof; H Vlassara
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

5.  Binding of Amadori glucose-modified albumin by the monocytic cell line MonoMac 6 activates protein kinase C epsilon protein tyrosine kinases and the transcription factors AP-1 and NF-kappaB.

Authors:  R Salazar; R Brandt; S Krantz
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

Review 6.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

7.  Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro.

Authors:  Wei Liu; Ge Z Xu; Chun H Jiang; Jie Tian
Journal:  BMC Cell Biol       Date:  2011-01-25       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.